— Thermo Fisher Scientific (NYSE: TMO) reported third-quarter 2019 earnings of $2.94 per share, vs. $2.87 per share expected.
— Revenues grew 6% to $6.27 billion, vs. $6.18 billion expected.
— Raised FY19 revenue guidance to $25.34 – $25.50 billion vs. prior guidance of $25.30 – $25.50 billion.
— Adjusted EPS guidance for FY19 raised to a new range of $12.28 – $12.34, vs. earlier guidance of $12.16 – $12.26.
— TMO shares have gained 28% since the beginning of this year.
Most Popular
Expanding portfolio to help Elastic (ESTC) strengthen foothold in SaaS market
Elastic N.V. (NYSE: ESTC), the company that pioneered enterprise search technology, has been thriving on the growing adoption of its products while innovating the portfolio. A steady improvement in revenue
3 Warren Buffett tech stocks to buy and hold for the next decade
Investing in the equity markets is not easy if you are trying to identify individual stocks for long-term gains. It is even more difficult if you are eyeing investments in
Key highlights from PepsiCo Q2 2020 earnings results announcement
PepsiCo Inc. (NASDAQ: PEP) reported second quarter 2020 earnings results today. Revenues declined 3.1% to $15.9 billion. Reported EPS fell 18% to $1.18 while core EPS amounted to $1.32. Due